Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Galle

Showing results (241-250 of 709) with videos related to

Pageof 71
Sort By:
Internal Medicine Journal|January 24, 2014
Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoidsF Darstein, S Kirschey, S Heckl, et al.
Clinical Case Reports|May 23, 2023
<i>Entamoeba histolytica</i>-associated proctitis and ileitis mimicking Crohn's disease-A case reportThomas Griemert, Ekkehard Siegel, Moritz Brandstetter, et al.
Gastrointestinal Endoscopy|October 7, 2003
Mini-laparoscopically guided percutaneous gastrostomy and jejunostomyUlrike Denzer, Klaus Mergener, Stefan Kanzler, et al.
Journal of Clinical Apheresis|January 22, 2009
Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complicationsThomas Thomaidis, Corinna Schorn, Wolfram Flaig, et al.
Medicine|December 17, 2020
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosisChristian Labenz, Karel Kostev, Peter R Galle, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 28, 2012
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis BJens M Kittner, Martin F Sprinzl, Annette Grambihler, et al.
Clinical and Translational Medicine|September 14, 2022
Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
The Journal of Rheumatology|December 4, 2009
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosusHannes Cash, Manfred Relle, Julia Menke, et al.
Digestive Diseases (Basel, Switzerland)|August 29, 2018
Feasibility Trial of the Newly Introduced Optical Enhancement Technology in Patients with Gastroesophageal Reflux DiseaseThomas Thomaidis, Fareed Rahman, Florian Thieringer, et al.
Pageof 71

Showing results (241-250 of 709) with videos related to

Sort By:
Pageof 71
Internal Medicine Journal|January 24, 2014
Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoidsF Darstein, S Kirschey, S Heckl, et al.
Clinical Case Reports|May 23, 2023
<i>Entamoeba histolytica</i>-associated proctitis and ileitis mimicking Crohn's disease-A case reportThomas Griemert, Ekkehard Siegel, Moritz Brandstetter, et al.
Gastrointestinal Endoscopy|October 7, 2003
Mini-laparoscopically guided percutaneous gastrostomy and jejunostomyUlrike Denzer, Klaus Mergener, Stefan Kanzler, et al.
Journal of Clinical Apheresis|January 22, 2009
Immunoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complicationsThomas Thomaidis, Corinna Schorn, Wolfram Flaig, et al.
Medicine|December 17, 2020
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosisChristian Labenz, Karel Kostev, Peter R Galle, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 28, 2012
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis BJens M Kittner, Martin F Sprinzl, Annette Grambihler, et al.
Clinical and Translational Medicine|September 14, 2022
Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
The Journal of Rheumatology|December 4, 2009
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosusHannes Cash, Manfred Relle, Julia Menke, et al.
Digestive Diseases (Basel, Switzerland)|August 29, 2018
Feasibility Trial of the Newly Introduced Optical Enhancement Technology in Patients with Gastroesophageal Reflux DiseaseThomas Thomaidis, Fareed Rahman, Florian Thieringer, et al.
Pageof 71